HLA-Haploidentical Bone Marrow Transplantation for Hematologic Malignancies Using Nonmyeloablative Conditioning and High-Dose, Posttransplantation Cyclophosphamide
Leo Luznik(Johns Hopkins University), Ephraim J. Fuchs(Johns Hopkins University), Elizabeth B. Harrington(Fred Hutch Cancer Center), Mary E.D. Flowers(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Ted Gooley(Fred Hutch Cancer Center), Michele Kaup(Sidney Kimmel Comprehensive Cancer Center), William Matsui(The University of Texas at Austin), Jonathan D. Powell(Enzo Life Sciences (United States)), Ivan Borrello(Tampa General Hospital), M. Susan Leffell(Sidney Kimmel Comprehensive Cancer Center), Richard J. Jones(Sidney Kimmel Comprehensive Cancer Center), Paul V. O’Donnell(Johns Hopkins Hospital), Marianna Zahurak(Bloomberg (United States)), Richard F. Ambinder(Johns Hopkins University), Robert A. Brodsky(Johns Hopkins University), Brenda M. Sandmaier(University of Washington), Rainer Storb(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Allen Chen(Johns Hopkins University), Carol Ann Huff(Sidney Kimmel Comprehensive Cancer Center), S. Warnock(Fred Hutch Cancer Center), Javier Bolaños‐Meade(Johns Hopkins University), S Piantadosi(Sidney Kimmel Comprehensive Cancer Center), Heather J. Symons(Johns Hopkins University)
Cited by 1,900
Related Papers
National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group Report
|Biology of Blood and Marrow Transplantation|2014|5.4k
Chronic graft-versus-host syndrome in man
|The American Journal of Medicine|1980|2.4k
Neoadjuvant PD-1 Blockade in Resectable Lung Cancer
|New England Journal of Medicine|2018|2.1k
Methotrexate and Cyclosporine Compared with Cyclosporine Alone for Prophylaxis of Acute Graft versus Host Disease after Marrow Transplantation for Leukemia
|New England Journal of Medicine|1986|1.5k